If you go to “icr.ac.uk” you will find an interesting article about how Zytiga was developed more than 20 years ago by the Institute of Cancer Research in the U.K. Johnson and Johnson bought rights to the drug a few years ago for less than $1 billion...an amount returned to them many times over.
Zytiga History : If you go to “icr.ac... - Advanced Prostate...
Zytiga History
Thanks, Mkeman. ALSO on the ICR website is a brief story from June 2018 on ICR's position when the UK's National Institute for Health and Care Excellence ("NICE") decided against recommending Zytiga as a first line treatment in advanced PC. (NOTE: For us Yanks, NICE is roughly equivalent to the National Institutes of Health (NIH)).
It really just goes to show that there is no true consensus on advanced PC in the medical community. Additionally, as these types of institutional recommendations are often used in the U.S. (and elsewhere, I'm sure, by the centralized health service) by insurance companies to determine courses of treatment and "standard of care," it just leads to those creeping "what-ifs" in our lives.... - Joe M.
Go to the link and put zytiga development in search bar. A few things pop up but you will find a link to fairly short article on development. The ICR "expressed disappointment". If I lived across the pond I would be expressing a little more than just disappointment. I certainly am not suggesting turning a few governmental cars over and setting them on fire. I certainly am not suggesting that.
The ICR priced its primo drug out of the reach of many patients when it sold Abiraterone rights for £600,000 to Johnson and Johnson.
Had several interesting conversations with Dr. Potter, the inventor of zytiga.Hard work and an obsession to develop the drug almost cost him his sanity.
I understand it was a team of five equally dedicated scientists and their picture is on the ICR site referenced above. Did he have anything to say about the fact that his pill is selling for $100 each?